TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35289316 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35289316 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study 35289329 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35289396 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 35289662 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 35289694 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35289736 — Predictive Biomarker (PRD): DNER mRNA
Genes: DNER; BET; UNQ262/PRO299
Study 35291289 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35291977 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35292700 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35292724 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 35292724 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 35292802 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35293696 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 35294522 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 35294522 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 35294522 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 35294522 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 35294527 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 35294811 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study 35295591 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35295591 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35295665 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35296845 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study 35296975 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35296975 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35296975 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35296975 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35296975 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 35297025 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 35298698 — Predictive Biomarker (PRD): Microsatellite instability
Study 35299035 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35299248 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35299273 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35301677 — Predictive Biomarker (PRD): SLC25A20 mRNA
Genes: SLC25A20; CAC; CACT
Study 35301985 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35302622 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 35302958 — Surrogate Endpoint (SUR): Blood pressure
Study 35302959 — Predictive Biomarker (PRD): SAA1 mRNA
Genes: SAA1
Study 35303070 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35303070 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35303173 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35303517 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 35303517 — Predictive Biomarker (PRD): CYP24A1 mRNA
Genes: CYP24A1; CYP24
Study 35303517 — Predictive Biomarker (PRD): PLAGL1 mRNA
Genes: PLAGL1; LOT1; ZAC
Study 35303517 — Predictive Biomarker (PRD): CMTM1 mRNA
Genes: CMTM1; CKLFSF1
Study 35303517 — Predictive Biomarker (PRD): DLX5 mRNA
Genes: DLX5
Study 35303517 — Predictive Biomarker (PRD): LY6D mRNA
Genes: LY6D; E48
Study 35304729 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 35304729 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 35305102 — Safety Biomarker (SAF): C-X-C motif chemokine 5
Genes: CXCL5; ENA78; SCYB5
Study 35305102 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study 35305102 — Predictive Biomarker (PRD): UMODL1 mRNA
Genes: UMODL1
Study 35305260 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35305400 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35305556 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 35305556 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35305556 — Safety Biomarker (SAF): miR-15a
Genes: MIR15A
Study 35305556 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study 35305556 — Safety Biomarker (SAF): miR-192
Genes: MIR192
Study 35305556 — Safety Biomarker (SAF): miR-423
Genes: MIR423
Study 35305596 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35305895 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35307611 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35307761 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study 35307972 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35308034 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35308535 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 35308563 — Surrogate Endpoint (SUR): Blood pressure
Study 35309087 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35309087 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35309363 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35310961 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35310985 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 35310985 — Surrogate Endpoint (SUR): Blood pressure
Study 35313956 — Safety Biomarker (SAF): Vitamin K-dependent protein S
Genes: PROS1; PROS
Study 35313956 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 35314692 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35314692 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study 35314693 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study 35314693 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35314693 — Predictive Biomarker (PRD): Hormone receptor
Study 35314720 — Predictive Biomarker (PRD): SPDEF mRNA
Genes: SPDEF; PDEF; PSE
Study 35314788 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 35314788 — Surrogate Endpoint (SUR): Blood pressure
Study 35314842 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35314843 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35314843 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 35315601 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 35315687 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35315780 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study 35316922 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 35316922 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35319467 — Predictive Biomarker (PRD): PTMS mRNA
Genes: PTMS
Study 35319467 — Surrogate Endpoint (SUR): Blood pressure
Study 35319502 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 35319751 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 35319751 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 35320489 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35320489 — Surrogate Endpoint (SUR): Blood pressure
Study 35320489 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35320489 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 35320489 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 35320489 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35320878 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 35321427 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35321427 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35321427 — Predictive Biomarker (PRD): Hormone receptor
Study 35321501 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 35321652 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study 35321744 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 35322185 — Predictive Biomarker (PRD): SBDS mRNA
Genes: SBDS; CGI-97
Study 35322287 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 35322553 — Predictive Biomarker (PRD): C1QTNF6 mRNA
Genes: C1QTNF6; CTRP6; UNQ581/PRO1151
Study 35322553 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35322677 — Surrogate Endpoint (SUR): Blood pressure
Study 35323932 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35323932 — Monitoring Biomarker (MOI): Procalcitonin
Study 35323932 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35323932 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35323932 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 35324532 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 35324532 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 35324532 — Predictive Biomarker (PRD): FOXD1 mRNA
Genes: FOXD1; FKHL8; FREAC4
Study 35325195 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC
Study 35325211 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 35325225 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35325225 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 35325225 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study 35327522 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study 35327522 — Predictive Biomarker (PRD): TM6SF2 mRNA
Genes: TM6SF2
Study 35327522 — Predictive Biomarker (PRD): MBOAT7 mRNA
Genes: MBOAT7; BB1; LENG4; OACT7
Study 35327522 — Predictive Biomarker (PRD): GCKR mRNA
Genes: GCKR
Study 35327546 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 35327546 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 35327546 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 35331335 — Predictive Biomarker (PRD): BCL11B mRNA
Genes: BCL11B; CTIP2; RIT1
Study 35332036 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 35332134 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35332278 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35332334 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35332334 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35333737 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 35337339 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study 35337750 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 35337972 — Predictive Biomarker (PRD): Hormone receptor
Study 35338084 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 35338084 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35338773 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35339285 — Surrogate Endpoint (SUR): Blood pressure
Study 35339664 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 35340264 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35340685 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 35340685 — Surrogate Endpoint (SUR): Pathological complete response
Study 35341327 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 35342321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35342457 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 35342822 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35342978 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 35343187 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35343188 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35343188 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35344040 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 35344040 — Safety Biomarker (SAF): Reactive oxygen species
Study 35344588 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 35344588 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study 35344588 — Predictive Biomarker (PRD): POU2F1 mRNA
Genes: POU2F1; OCT1; OTF1
Study 35344588 — Predictive Biomarker (PRD): SLC47A1 mRNA
Genes: SLC47A1; MATE1
Study 35344588 — Predictive Biomarker (PRD): SLC22A2 mRNA
Genes: SLC22A2; OCT2
Study 35344588 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 35345247 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 35346046 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 35346046 — Surrogate Endpoint (SUR): Blood pressure
Study 35346138 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35346219 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 35346458 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35347559 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 35347559 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 35349331 — Predictive Biomarker (PRD): LYVE1 mRNA
Genes: LYVE1; CRSBP1; HAR; XLKD1; UNQ230/PRO263
Study 35349631 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35349631 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35349683 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35350938 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 35350938 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 35351093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35351181 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35351181 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 35351823 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study 35352025 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35352313 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 35352512 — Predictive Biomarker (PRD): Microsatellite instability
Study 35352604 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35353154 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 35353219 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 35353219 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study 35353263 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35354561 — Predictive Biomarker (PRD): VILL mRNA
Genes: VILL
Study 35354561 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 35354808 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 35354808 — Safety Biomarker (SAF): Reactive oxygen species
Study 35355147 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35355147 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 35355397 — Predictive Biomarker (PRD): Liver iron
Study 35355438 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 35355438 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 35355438 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35355991 — Predictive Biomarker (PRD): PDK4 mRNA
Genes: PDK4; PDHK4
Study 35355991 — Predictive Biomarker (PRD): HMGCR mRNA
Genes: HMGCR
Study 35356197 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35356262 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35356726 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study 35357325 — Surrogate Endpoint (SUR): Blood pressure
Study 35358290 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 35358290 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35358443 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35358442 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 35358442 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 35358442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 35358442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 35358442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study 35358998 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35358998 — Safety Biomarker (SAF): CDA
Genes: CDD
Study 35359000 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35359139 — Surrogate Endpoint (SUR): Blood pressure
Study 35359899 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 35360224 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35360522 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 35361478 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 35361478 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35361478 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35361691 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35361691 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35362047 — Predictive Biomarker (PRD): CBLB mRNA
Genes: CBLB; RNF56; Nbla00127
Study 35362522 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 35362862 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 35363252 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 35363564 — Predictive Biomarker (PRD): PIGU mRNA
Genes: PIGU; CDC91L1; PSEC0205; UNQ3055/PRO9875
Study 35365547 — Surrogate Endpoint (SUR): Blood pressure
Study 35365828 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 35366378 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35366432 — Surrogate Endpoint (SUR): Blood pressure
Study 35366613 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35366820 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study 35366825 — Surrogate Endpoint (SUR): Pathological complete response
Study 35366920 — Surrogate Endpoint (SUR): Blood pressure
Study 35366963 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35368221 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 35368221 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study 35371427 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 35371427 — Surrogate Endpoint (SUR): Hematologic response
Study 35372008 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 35372393 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 35372393 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 35372473 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study 35373105 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35373299 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 35377104 — Surrogate Endpoint (SUR): Bone mineral density
Study 35377184 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 35377184 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35377184 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 35378489 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35378489 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 35378634 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35378634 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35378634 — Predictive Biomarker (PRD): Hormone receptor
Study 35378640 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 35378952 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35379237 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35379615 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 35379635 — Surrogate Endpoint (SUR): Blood pressure
Study 35379641 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35379737 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35379845 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study 35379963 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35379979 — Predictive Biomarker (PRD): CEP290 mRNA
Genes: CEP290; BBS14; KIAA0373; NPHP6
Study 35380673 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 35381327 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 35381950 — Safety Biomarker (SAF): Thyroid stimulating hormone